Nutex Health, Inc.
NUTX
NASDAQ·Healthcare·Medical - Care Facilities·Mkt cap $1.3B
$193.24
▼ -2.25%
P/E
7.53
Mkt Cap
$1.3B
52-Wk Range
$80.53–$204.00
52-Week Range
$80.53 - $204.00
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 131.7% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Proprietary cloud-based technology platform enabling integrated data analytics across multiple healthcare settings
- Dual-revenue model combining facility operations with management services and population health contracts
- Established network of 21 owned and operated facilities providing operational scale and referral relationships
- Micro-hospital expertise in underserved markets with lower capital requirements than traditional hospitals
Bear Case
1 risk
- High volatility (beta 2.0). Larger-than-normal price swings expected.
Growth
Stable outlook
Expansion of micro-hospital footprint in high-demand, underserved markets
Value
Trading at 0.3x Healthcare IT & Services peers — a discount despite the growth profile.
Momentum
Hot
+43.8% over 3m
Quality
Strong
High-growth business (7% revenue growth, 51% gross margin). Profitable with strong growth momentum.
Dividend
None
No dividend
Smart-money signal
Who's buying NUTX right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 17, 2026
AUG 6, 2026
Reported EPS of $9.38 vs $4.95 consensus (+89.5% surprise). Revenue of $210.8M vs $215.0M expected (-2.0%).
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+89.5%
Revenue trend · last 8Q
—
+270%
+214%
+221%
+240%
-41%
+2%
-14%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$78.8M
$257.6M
$211.8M
$244.0M
$267.8M
$151.7M
$216.5M
$210.8M
Margins · last 8Q
Gross
67.0%
Operating
57.8%
Profit
31.2%
Wall Street consensus
2 analysts · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: B. Riley · Sep 4, 2026
vs Industry
How NUTX stacks vs Medical - Care Facilities
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related